-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Eiger BioPharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2023.
- Eiger BioPharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$24M, a 30% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$74.5M, a 10.2% increase from 2022.
- Eiger BioPharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$83M, a 16.4% decline from 2021.
- Eiger BioPharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$71.3M, a 12.9% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)